Editorial: Astrocyte-Targeted Therapeutic Strategies for Neurological Disorders

E-ISSN： 1873-4286|23|33|4933-4935

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.33, 2018-01, pp. : 4933-4935

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: Microglia - A Therapeutic Target in Neurological Diseases and Disorders)

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 6, 2013-09 ,pp. : 719-719

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Strategy of Erythropoietin in Neurological Disorders

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 3, 2008-06 ,pp. : 227-234

Bentham Science Publishers

Access to resources Recommend Favorite

Davunetide: Peptide Therapeutic in Neurological Disorders

Current Medicinal Chemistry, Vol. 21, Iss. 23, 2014-08 ,pp. : 2591-2598

Bentham Science Publishers

Access to resources Recommend Favorite

The Therapeutic Potential of Statins in Neurological Disorders

Current Medicinal Chemistry, Vol. 14, Iss. 1, 2007-01 ,pp. : 103-112

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of mGlu Receptors in Hippocampal Plasticity Deficits in Neurological and Psychiatric Disorders: Implications for Allosteric Modulators as Novel Therapeutic Strategies

Current Neuropharmacology, Vol. 14, Iss. 5, 2016-06 ,pp. : 455-473

Bentham Science Publishers

Access to resources Recommend Favorite